Product category
OTC Products
6 public development records. Search this category and review proposed presentations, evidence limits and attributed references.
- Records
- 6
- Medicines
- 6
- Devices / diagnostics
- 0
- Presentations represented
- 2
Public development records
OTC Products records
Category placement supports navigation. It does not establish an approved indication, suitability for a particular patient group, prescription status or eligibility for supply.
Showing 6 of 6 records
Portfolio records
| Record | Dosage form / type | Proposed strength / configuration | Proposed pack | Status |
|---|---|---|---|---|
| Aluminium hydroxide + Magnesium hydroxide Oral suspensionLP-217 | Oral suspensionMedicine | Al(OH)3 320 mg + Mg(OH)2 400 mg/5 mL | Bottle 120 mL / 200 mL | Development record |
| Cetirizine TabletsLP-218 | TabletMedicine | 10 mg | Blister 10 x 10 tablets | Development record |
| Chlorpheniramine maleate TabletsLP-219 | TabletMedicine | 4 mg | Blister 10 x 10 tablets | Development record |
| Diclofenac sodium TabletsLP-220 | TabletMedicine | 50 mg | Blister 10 x 10 tablets | Development record |
| Ibuprofen TabletsLP-221 | TabletMedicine | 200 mg; 400 mg | Blister 10 x 10 tablets | Development record |
| Loratadine TabletsLP-222 | TabletMedicine | 10 mg | Blister 10 x 10 tablets | Development record |
No matching record.
Try a broader generic name, another presentation or a portfolio reference.
Professional enquiries
Enquire about this product category.
Include the generic name or portfolio reference, your organisation and destination country.